Literature DB >> 8619520

Experimental sensory neuropathy induced by sensitization with ganglioside GD1b.

S Kusunoki1, J Shimizu, A Chiba, Y Ugawa, S Hitoshi, I Kanazawa.   

Abstract

Three of six rabbits immunized with purified GD1b developed ataxic sensory neuropathy. They laid on the floor with their limbs splayed out, and their movements were awkward; but muscle power, tonus, and superficial sensation appeared to be intact. Sciatic nerve motor conduction studies were normal. Axonal degeneration was present in the dorsal column of the spinal cord, in the dorsal roots, and in the sciatic nerve. Some of the nerve cell bodies in the dorsal root ganglia had degenerated and disappeared. No demyelinative lesions or mononuclear cell infiltrations were seen in those regions. No pathological changes were present in the other three immunized rabbits that showed no clinical symptoms. Control rabbits inoculated only with adjuvants showed neither clinical symptoms nor pathological changes. Anti-GD1b antibody was raised in the sera from all six rabbits immunized with GD1b. The monoclonal anti-GD1b antibody GGR12 immunostained about one-half the rabbit primary sensory neurons. Sensitization with GD1b, therefore, may cause ataxic sensory neuropathy in rabbits due to antibody-mediated damage to the primary sensory neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8619520     DOI: 10.1002/ana.410390404

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  26 in total

Review 1.  Specificity of antiglycolipid antibodies.

Authors:  N Baumann
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

2.  Posterior column involvement in Miller Fisher syndrome or dorsal root ganglion neuronopathy?

Authors:  Hai-feng Li; Yan-chen Xie
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

3.  Quantitative retention of membrane lipids in the freeze-fracture replica.

Authors:  Akikazu Fujita; Toyoshi Fujimoto
Journal:  Histochem Cell Biol       Date:  2007-09-18       Impact factor: 4.304

4.  Molecular mimicry: sensitization of Lewis rats with Campylobacter jejuni lipopolysaccharides induces formation of antibody toward GD3 ganglioside.

Authors:  Seigo Usuki; Stuart A Thompson; Michael H Rivner; Kyoji Taguchi; Keiko Shibata; Toshio Ariga; Robert K Yu
Journal:  J Neurosci Res       Date:  2006-02-01       Impact factor: 4.164

Review 5.  Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants.

Authors:  J W Terryberry; Y Shoenfeld; J B Peter
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 6.  Animal models of autoimmune neuropathy.

Authors:  Betty Soliven
Journal:  ILAR J       Date:  2014

7.  Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

Authors:  C S Goodyear; G M O'Hanlon; J J Plomp; E R Wagner; I Morrison; J Veitch; L Cochrane; R W Bullens; P C Molenaar; J Conner; H J Willison
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 8.  Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.

Authors:  Pallavi Asthana; Joaquim Si Long Vong; Gajendra Kumar; Raymond Chuen-Chung Chang; Gang Zhang; Kazim A Sheikh; Chi Him Eddie Ma
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

9.  Nanoscale analysis reveals no domain formation of glycosylphosphatidylinositol-anchored protein SAG1 in the plasma membrane of living Toxoplasma gondii.

Authors:  Yuna Kurokawa; Tatsunori Masatani; Rikako Konishi; Kanna Tomioku; Xuenan Xuan; Akikazu Fujita
Journal:  Histochem Cell Biol       Date:  2019-09-21       Impact factor: 4.304

10.  The pattern and diagnostic criteria of sensory neuronopathy: a case-control study.

Authors:  Jean-Philippe Camdessanché; Guillemette Jousserand; Karine Ferraud; Christophe Vial; Philippe Petiot; Jérôme Honnorat; Jean-Christophe Antoine
Journal:  Brain       Date:  2009-06-08       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.